3D Systems Corp

More Details of 3D Systems Corp Company

3D Systems Corporation is an additive manufacturing solutions company. The Company provides three dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. Its segments include Healthcare Solutions and Industrial Solutions. Healthcare Solutions segment includes various industry verticals, such as dental, medical devices, personalized health services and regenerative medicine. Industrial Solutions segment includes various industry verticals, such as aerospace, defense, transportation and general manufacturing. It architects solutions specific to customers' needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.

Company Info

Ticker SymbolDDD

Company name3D Systems Corp

IPO dateMar 26, 2011

CEODr. Jeffrey A. (Jeff) Graves, Ph.D.

Number of employees1833

Security typeOrdinary Share

Fiscal year-endMar 26

Address333 Three D Systems Cir

CityROCK HILL

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code29730

Phone18033263900

Websitehttps://www.3dsystems.com/

Ticker SymbolDDD

IPO dateMar 26, 2011

CEODr. Jeffrey A. (Jeff) Graves, Ph.D.

Company Executives

Name

Name/Position

Position

Shareholding

Change

Dr. Charles W. Hull

Executive Vice President, Chief Technology Officer - Regenerative Medicine

593.05K

-0.82%

Mr. Reji Puthenveetil

Executive Vice President - Additive Solutions, Chief Commercial Officer

431.53K

-3.59%

Mr. Kevin S. Moore

Independent Director

271.70K

+11.98%

Dr. John J. Tracy

Independent Director

180.71K

+19.17%

Dr. Vasant Padmanabhan

Independent Director

147.18K

+24.61%

Ms. Malissia R. Clinton

Independent Director

--

Mr. Charles G. (Chip) Mcclure, Jr.

Independent Chairman of the Board

--

Mr. Joseph (Joe) Zuiker

Executive Vice President - Engineering and Operations

--

Mr. Jimmy D. (Jim) Kever, J.D.

Independent Director

--

Ms. Phyllis Nordstrom

Interim Chief Financial Officer, Principal Accounting Officer

--

Name

Name/Position

Position

Shareholding

Change

Dr. Charles W. Hull

Executive Vice President, Chief Technology Officer - Regenerative Medicine

593.05K

-0.82%

Mr. Reji Puthenveetil

Executive Vice President - Additive Solutions, Chief Commercial Officer

431.53K

-3.59%

Mr. Kevin S. Moore

Independent Director

271.70K

+11.98%

Dr. John J. Tracy

Independent Director

180.71K

+19.17%

Dr. Vasant Padmanabhan

Independent Director

147.18K

+24.61%

Ms. Malissia R. Clinton

Independent Director

--

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

Products

54.72M

57.88%

Services

39.82M

42.12%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Products

54.72M

57.88%

Services

39.82M

42.12%

Shareholding Stats

Updated: Sun, Aug 17

Shareholders

Shareholder Types

Shareholders

Proportion

State Street Global Advisors (US)

7.71%

BlackRock Institutional Trust Company, N.A.

7.20%

The Vanguard Group, Inc.

5.77%

Geode Capital Management, L.L.C.

2.47%

Millennium Management LLC

2.46%

Other

74.39%

Shareholders

Proportion

State Street Global Advisors (US)

7.71%

BlackRock Institutional Trust Company, N.A.

7.20%

The Vanguard Group, Inc.

5.77%

Geode Capital Management, L.L.C.

2.47%

Millennium Management LLC

2.46%

Other

74.39%

Shareholder Types

Shareholders

Proportion

Investment Advisor

23.49%

Investment Advisor/Hedge Fund

17.11%

Hedge Fund

6.38%

Individual Investor

4.28%

Research Firm

3.93%

Family Office

1.11%

Bank and Trust

0.17%

Venture Capital

0.15%

Pension Fund

0.08%

Other

43.29%

Institutional Shareholding

Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

570

68.79M

50.43%

-21.87M

2025Q1

587

72.49M

53.18%

-18.98M

2024Q4

592

79.50M

58.62%

-5.75M

2024Q3

589

77.38M

57.87%

-20.75M

2024Q2

584

90.33M

67.61%

-8.75M

2024Q1

591

91.23M

68.27%

-11.77M

2023Q4

599

91.77M

68.70%

-8.99M

2023Q3

605

90.63M

67.88%

-16.10M

2023Q2

615

94.67M

72.15%

-10.52M

2023Q1

640

92.61M

71.04%

-9.20M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

State Street Global Advisors (US)

5.97M

4.37%

+2.04K

+0.03%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

9.01M

6.6%

+93.54K

+1.05%

Mar 31, 2025

The Vanguard Group, Inc.

7.30M

5.35%

+193.56K

+2.72%

Mar 31, 2025

Geode Capital Management, L.L.C.

3.06M

2.24%

+74.90K

+2.51%

Mar 31, 2025

Millennium Management LLC

1.62M

1.19%

-1.97M

-54.82%

Mar 31, 2025

Two Sigma Investments, LP

2.70M

1.98%

-226.90K

-7.75%

Mar 31, 2025

ICON Advisers, Inc.

2.10M

1.54%

+500.00K

+31.25%

Mar 31, 2025

Silverberg Bernstein Capital Management, LLC

1.53M

1.12%

+210.81K

+15.93%

Mar 31, 2025

Morgan Stanley & Co. LLC

992.58K

0.73%

-95.32K

-8.76%

Mar 31, 2025

Related ETFs

Name

Proportion

No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

2.470USD

3D Systems Corp

2.470

Overview

Company

Financials

Analysis